Metaraminol

CHEMBL1201319 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

167.2 g/mol

LogP

-0.4

Phase

4

A vasopressor medication used to treat dangerously low blood pressure (hypotension), particularly during surgery or as a result of drug reactions. It works by constricting blood vessels to raise blood pressure.

Masse moléculaire

167,2000 g/mol

LogP

-0,40

TPSA

66,50 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@H](N)[C@H](O)c1cccc(O)c1

InChI

InChI=1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3/t6-,9-/m0/s1

Molecular Formula

C9H13NO2

HBD / HBA

3 / 3

Liaisons Rotatives

2

Atomes Lourds

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A vasopressor medication used to treat dangerously low blood pressure (hypotension), particularly during surgery or as a result of drug reactions. It works by constricting blood vessels to raise blood pressure.

Yes, Metaraminol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201319. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5906. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Metaraminol sur PillFYI

Structure

Données Clés

Formule: C9H13NO2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.